SI9200286B - Complex salts of hematoporphyrin and its derivatives, their synthesis and therapeutic agent - Google Patents
Complex salts of hematoporphyrin and its derivatives, their synthesis and therapeutic agent Download PDFInfo
- Publication number
- SI9200286B SI9200286B SI9200286A SI9200286A SI9200286B SI 9200286 B SI9200286 B SI 9200286B SI 9200286 A SI9200286 A SI 9200286A SI 9200286 A SI9200286 A SI 9200286A SI 9200286 B SI9200286 B SI 9200286B
- Authority
- SI
- Slovenia
- Prior art keywords
- carboxy
- ethylamino
- formula
- propylamino
- mixture
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract 22
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical class CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 title claims abstract 6
- 239000003814 drug Substances 0.000 title claims abstract 5
- 229940124597 therapeutic agent Drugs 0.000 title claims abstract 5
- 229960003569 hematoporphyrin Drugs 0.000 title claims abstract 4
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- -1 carboxymethylamino Chemical group 0.000 claims abstract 22
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract 7
- 150000001413 amino acids Chemical class 0.000 claims abstract 6
- 238000000034 method Methods 0.000 claims abstract 6
- 206010028980 Neoplasm Diseases 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 4
- 239000003960 organic solvent Substances 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Chemical group NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical group OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical group NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- 239000004472 Lysine Chemical group 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Chemical group NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Chemical group NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 claims 2
- 229940015493 dihematoporphyrin ether Drugs 0.000 claims 2
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical group NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Chemical group OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Chemical group NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000012456 homogeneous solution Substances 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 239000011833 salt mixture Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000027455 binding Effects 0.000 abstract 1
- 238000009739 binding Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL91292220A PL165249B1 (pl) | 1991-10-29 | 1991-10-29 | Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SI9200286A SI9200286A (en) | 1993-06-30 |
| SI9200286B true SI9200286B (en) | 2001-06-30 |
Family
ID=20055985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9200286A SI9200286B (en) | 1991-10-29 | 1992-10-29 | Complex salts of hematoporphyrin and its derivatives, their synthesis and therapeutic agent |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5451599A (da) |
| EP (1) | EP0539960B1 (da) |
| JP (1) | JP3020759B2 (da) |
| CN (1) | CN1040328C (da) |
| BG (1) | BG61648B1 (da) |
| CA (1) | CA2081605C (da) |
| CZ (1) | CZ281694B6 (da) |
| DE (1) | DE69217819T2 (da) |
| DK (1) | DK0539960T3 (da) |
| FI (1) | FI100243B (da) |
| HR (1) | HRP921337B1 (da) |
| LV (1) | LV11952B (da) |
| NO (1) | NO300499B1 (da) |
| PL (1) | PL165249B1 (da) |
| RU (1) | RU2122003C1 (da) |
| SI (1) | SI9200286B (da) |
| UA (1) | UA40568C2 (da) |
| YU (1) | YU48961B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO180167C (no) | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
| US5948771A (en) * | 1996-01-31 | 1999-09-07 | The Trustees Of Columbia University In The City Of New York | Method for treating heart failure using tetrapyrroles and metallotetrapyrroles |
| GB9606293D0 (en) * | 1996-03-26 | 1996-05-29 | William Harvey Research Limite | Treatment of cancers and other tumours |
| AU2002220853B2 (en) | 2000-11-29 | 2007-06-28 | Pci Biotech As | Photochemical internalization for delivery of molecules into the cytosol |
| CN100490902C (zh) | 2000-11-29 | 2009-05-27 | Pci生物技术联合股份有限公司 | 病毒介导的分子传递进入胞质溶胶的光化学内在化 |
| CN104130266A (zh) * | 2013-05-02 | 2014-11-05 | 中国医学科学院生物医学工程研究所 | 一种新型原卟啉衍生物及制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2912M (fr) * | 1963-07-24 | 1964-11-09 | Rech S Pharma E R P H A R Soc | Dichlorhydrate d'hématoporphyrinate de procaine. |
| ATE84036T1 (de) * | 1985-10-23 | 1993-01-15 | Nihon Mediphysics Co Ltd | Porphyrinderivate, ihre herstellung und verwendung. |
| US4882234A (en) * | 1986-11-12 | 1989-11-21 | Healux, Inc. | Storage-stable porphin compositions and a method for their manufacture |
| US4968715A (en) * | 1988-07-06 | 1990-11-06 | Health Research, Inc. | Use of purified hematoporphyrin trimers in photodynamic therapy |
| US5190966A (en) * | 1988-07-06 | 1993-03-02 | Health Research, Inc. | Purified hematoporphyrin dimers and trimers useful in photodynamic therapy |
| US4961920A (en) * | 1988-12-08 | 1990-10-09 | Luminis Pty, Ltd. | Phototherapeutic monovinyl and divinyl ether-linked dimers |
| CN102565846B (zh) * | 2011-12-30 | 2014-05-14 | 清华大学 | 蜂窝型热中子探测器 |
-
1991
- 1991-10-29 PL PL91292220A patent/PL165249B1/pl not_active IP Right Cessation
-
1992
- 1992-10-26 FI FI924856A patent/FI100243B/fi not_active IP Right Cessation
- 1992-10-28 DE DE69217819T patent/DE69217819T2/de not_active Expired - Lifetime
- 1992-10-28 EP EP92118447A patent/EP0539960B1/en not_active Expired - Lifetime
- 1992-10-28 CA CA002081605A patent/CA2081605C/en not_active Expired - Lifetime
- 1992-10-28 RU RU92004314/04A patent/RU2122003C1/ru not_active IP Right Cessation
- 1992-10-28 BG BG97030A patent/BG61648B1/bg unknown
- 1992-10-28 NO NO924151A patent/NO300499B1/no not_active IP Right Cessation
- 1992-10-28 DK DK92118447.9T patent/DK0539960T3/da active
- 1992-10-29 JP JP4291322A patent/JP3020759B2/ja not_active Expired - Lifetime
- 1992-10-29 US US07/968,434 patent/US5451599A/en not_active Expired - Lifetime
- 1992-10-29 CZ CS923252A patent/CZ281694B6/cs not_active IP Right Cessation
- 1992-10-29 CN CN92112561A patent/CN1040328C/zh not_active Expired - Fee Related
- 1992-10-29 YU YU94592A patent/YU48961B/sh unknown
- 1992-10-29 SI SI9200286A patent/SI9200286B/sl not_active IP Right Cessation
- 1992-11-24 HR HRP-945A patent/HRP921337B1/xx not_active IP Right Cessation
-
1993
- 1993-06-15 UA UA93002921A patent/UA40568C2/uk unknown
-
1997
- 1997-06-05 LV LVP-97-110A patent/LV11952B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU94592A (sh) | 1995-12-04 |
| CN1071914A (zh) | 1993-05-12 |
| FI924856A (fi) | 1993-04-30 |
| HRP921337B1 (en) | 2000-02-29 |
| US5451599A (en) | 1995-09-19 |
| CN1040328C (zh) | 1998-10-21 |
| CZ325292A3 (en) | 1993-09-15 |
| EP0539960A3 (en) | 1993-06-16 |
| CA2081605C (en) | 2002-02-26 |
| DE69217819D1 (de) | 1997-04-10 |
| EP0539960A2 (en) | 1993-05-05 |
| NO300499B1 (no) | 1997-06-09 |
| EP0539960B1 (en) | 1997-03-05 |
| CA2081605A1 (en) | 1993-04-30 |
| HRP921337A2 (en) | 1994-10-31 |
| SI9200286A (en) | 1993-06-30 |
| FI100243B (fi) | 1997-10-31 |
| NO924151D0 (no) | 1992-10-28 |
| FI924856A0 (fi) | 1992-10-26 |
| JPH05262775A (ja) | 1993-10-12 |
| BG61648B1 (bg) | 1998-02-27 |
| NO924151L (no) | 1993-04-30 |
| PL292220A1 (en) | 1993-09-20 |
| DE69217819T2 (de) | 1997-09-04 |
| UA40568C2 (uk) | 2001-08-15 |
| DK0539960T3 (da) | 1997-09-15 |
| BG97030A (bg) | 1994-03-24 |
| JP3020759B2 (ja) | 2000-03-15 |
| LV11952A (lv) | 1998-01-20 |
| LV11952B (en) | 1998-06-20 |
| PL165249B1 (pl) | 1994-11-30 |
| YU48961B (sh) | 2003-01-31 |
| RU2122003C1 (ru) | 1998-11-20 |
| CZ281694B6 (cs) | 1996-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4410688A (en) | Macromolecular highly branched homogeneous compound | |
| JP3352693B2 (ja) | ピロリドン基含有ポリエステル及びポリアミド | |
| EP0328529B1 (en) | Method for preparing polysubstituted diethylenetriaminepentaacetic acids | |
| PL313478A1 (en) | Substituted isoxazolins, method of obtaining them, agents containing such compounds and their application as antidote | |
| DE69032414D1 (de) | Diphenylmethane derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
| IE49647B1 (en) | Non-ionic x-ray contrast agents | |
| US5631244A (en) | mono(6-amino-6-deoxy)cyclodextrin derivatives substituted in the 6-position by an α-amino acid residue, process for their preparation and their uses | |
| US5473035A (en) | Process for preparing poly (glucaramides) | |
| SI9200286B (en) | Complex salts of hematoporphyrin and its derivatives, their synthesis and therapeutic agent | |
| RU2005122905A (ru) | Краска для струйной печати и регистрирующий материал | |
| EP0240370B1 (en) | N-acyl substituted cyclic ureas | |
| US6291634B1 (en) | Polyamino acid derivatives | |
| JP4543692B2 (ja) | 塩基性アミノ酸誘導体 | |
| WO2004096754A1 (ja) | 双頭型塩基性アミノ酸誘導体 | |
| KR19980702385A (ko) | 부식억제제로서 이미다졸리디논 유도체 | |
| US5359124A (en) | β-phenylisoserine derivative, its preparation and its use | |
| Ayfer et al. | Synthesis and antibacterial activities of new quaternary ammonium monomers | |
| JP2002194080A (ja) | 重合体及びその製造方法 | |
| FR2616785A1 (fr) | Composes guanidiniques comprenant un ion tetraphenylborate substitue et procede d'obtention de ces composes et utilisation des composes lors de la synthese peptidique | |
| HU210143B (en) | Process for producing amidofluoranited compounds | |
| JPS5947033B2 (ja) | ヒドロキシ多塩基酸塩型防錆剤 | |
| RU2406726C1 (ru) | ПРОИЗВОДНЫЕ 13(1)-N-{2-[N-(КЛОЗО-МОНОКАРБАДОДЕКАБОРАН-1-ИЛ)-МЕТИЛ]АМИНОЭТИЛ}АМИД-15(2),17(3)-ДИМЕТИЛОВОГО ЭФИРА ХЛОРИНА e6, ПРОЯВЛЯЮЩИЕ СВОЙСТВА ФОТОСЕНСИБИЛИЗАТОРА | |
| EP0245631A2 (en) | Chemical process for the preparation of oxamide derivatives. | |
| US6180116B1 (en) | Histidine derivatives, preparation process and uses | |
| Knaus et al. | Photoinitiators with functional groups. Part IV. Water-soluble photoinitiators containing quaternary ammonium groups |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF | Valid on the event date | ||
| KO00 | Lapse of patent |
Effective date: 20120531 |